Edmond de Rothschild Asset Management (France)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$46.9M Sell
1,459,579
-9,802
-0.7% -$328K 2.04% 11
2016
Q2
$49.1M Sell
1,469,381
-210,800
-13% -$6.73M 2.19% 10
2016
Q1
$47.2M Sell
1,680,181
-223,448
-12% -$6.38M 2.06% 9
2015
Q4
$58.3M Sell
1,903,629
-132,804
-7% -$4.18M 2.06% 9
2015
Q3
$60.7M Sell
2,036,433
-431,824
-17% -$13.8M 2% 10
2015
Q2
$78.5M Buy
+2,468,257
New +$80.4M 2.12% 10

Other funds holding PFE

Edmond de Rothschild Asset Management (France)'s PFE Position: Q3 2016 in Review

Edmond de Rothschild Asset Management (France) reduced its Pfizer (PFE) stake by 0.67% in Q3 2016, selling an estimated $328K and leaving 1,459,579 shares worth $46.9M. The position accounts for 2.04% of the portfolio, ranked #11.

Edmond de Rothschild Asset Management (France) first reported a position in PFE in Q2 2015 and has held it in 6 quarters since. The position peaked at $78.5M in Q2 2015. 1,963 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

  • Edmond de Rothschild Asset Management (France) held 1,459,579 shares of Pfizer worth $46.9M as of Q3 2016.
  • Edmond de Rothschild Asset Management (France) sold 9,802 Pfizer shares in Q3 2016, an estimated $328K.
  • Pfizer made up 2.04% of Edmond de Rothschild Asset Management (France)'s portfolio in Q3 2016, its #11 holding.
  • Edmond de Rothschild Asset Management (France) first reported a position in Pfizer in Q2 2015 and has held it in 6 quarters since.
  • Edmond de Rothschild Asset Management (France)'s Pfizer position peaked at $78.5M in Q2 2015.
  • 1,963 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Edmond de Rothschild Asset Management (France)'s 13F filing for Q3 2016, filed 14 Nov 2016.